Skip to Main Content

Advertisement

Skip Nav Destination

Noopur Raje, MD: Denosumab Versus ZA for Myeloma-Related Bone Disease

December 30, 2021
On location

Dr. Raje discusses results from a large phase III trial comparing denosumab with zoledronic acid for delaying the time to a skeletal-related complication in patients with myeloma.

Advertisement

Connect with us:

CURRENT ISSUE
August 2022

Advertisement

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement

X